Published in Neth Heart J on December 01, 2009
Genetic advances in sarcomeric cardiomyopathies: state of the art. Cardiovasc Res (2015) 1.19
Cardiomyopathies: a revolution in molecular medicine and cardiac imaging. Neth Heart J (2009) 0.82
Evaluation of hypertrophic cardiomyopathy: new horizons for CMR? Neth Heart J (2010) 0.81
Left ventricular mass assessment by CMR; how to define the optimal index. Int J Cardiovasc Imaging (2010) 0.75
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr (1990) 25.24
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation (1995) 6.55
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation (2003) 5.85
The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell (2002) 4.72
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol (2004) 3.47
Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol Genet Metab (2005) 2.72
Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab (2003) 2.42
Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation (2003) 2.12
Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet (2005) 2.04
Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2004) 1.83
Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation (2004) 1.82
Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Circulation (2008) 1.72
The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. Eur Heart J (2003) 1.70
Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol (1984) 1.67
Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc (2005) 1.65
Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol (2006) 1.63
A contemporary approach to hypertrophic cardiomyopathy. Circulation (2006) 1.53
Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol (2002) 1.47
MRI of hypertrophic cardiomyopathy: part I, MRI appearances. AJR Am J Roentgenol (2007) 1.26
Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart (2005) 1.24
Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience. Neth Heart J (2007) 1.23
Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations. Am J Physiol Heart Circ Physiol (2004) 1.03
Mutations profile in Chinese patients with hypertrophic cardiomyopathy. Clin Chim Acta (2005) 1.03
Impact of multiple gene mutations in determining the severity of cardiomyopathy and heart failure. Clin Exp Pharmacol Physiol (2008) 0.95
Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation. Am J Cardiol (1999) 0.94
Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy. Am Heart J (2008) 0.94
Molecular genetics of hypertrophic cardiomyopathy. Curr Cardiol Rep (2000) 0.87
The use of cardiac magnetic resonance imaging to determine the aetiology of left ventricular disease and cardiomyopathy. Heart (2008) 0.82
Beta-myosin heavy chain gene mutations and hypertrophic cardiomyopathy in Austrian children. J Mol Cell Cardiol (2001) 0.82
Abnormal cardiac response to exercise in a murine model of familial hypertrophic cardiomyopathy. Int J Cardiol (2006) 0.80
Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene. Am J Cardiol (2008) 0.79
Dual chamber pacemaker therapy in obstructive hypertrophic cardiomyopathy. Circulation (1995) 0.77
Suppression of gene silencing: a general strategy used by diverse DNA and RNA viruses of plants. Proc Natl Acad Sci U S A (1999) 5.82
QT lengthening and life-threatening arrhythmias associated with fexofenadine. Lancet (1999) 2.48
A-type lamins are essential for TGF-beta1 induced PP2A to dephosphorylate transcription factors. Hum Mol Genet (2005) 1.55
[Genetic cancer syndromes and reproductive choice: dialogue between parents and politicians on preimplantation genetic diagnosis]. Ned Tijdschr Geneeskd (2008) 1.43
Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension (1999) 1.23
Hereditary muscular dystrophies and the heart. Neuromuscul Disord (2010) 1.21
Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension (2000) 1.21
Activation of the beta globin locus by transcription factors and chromatin modifiers. EMBO J (2000) 1.08
Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D. Neth Heart J (2012) 0.99
High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril. J Am Coll Cardiol (1998) 0.97
FISH characterisation of an identical (16)(p11.2p12.2) tandem duplication in two unrelated patients with autistic behaviour. J Med Genet (2004) 0.96
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade. Br J Pharmacol (2003) 0.95
Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands. Neth Heart J (2010) 0.92
Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012. Hum Reprod Update (2013) 0.91
Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Am J Cardiol (2001) 0.90
MicroRNAs in heart failure: new targets in disease management. Clin Pharmacol Ther (2013) 0.90
Duplication of chromosome region (16)(p11.2 --> p12.1) in a mother and daughter with mild mental retardation. Am J Med Genet (2002) 0.87
Chronic beta-blocker treatment in patients with advanced heart failure. Effects on neurohormones. Int J Cardiol (2000) 0.86
The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J (1996) 0.86
Congenital hydrocephalus in clinical practice: a genetic diagnostic approach. Eur J Med Genet (2011) 0.85
Cytoplasmic localization of PML particles in laminopathies. Histochem Cell Biol (2012) 0.85
The uptake and outcome of prenatal and pre-implantation genetic diagnosis for Huntington's disease in the Netherlands (1998-2008). Clin Genet (2013) 0.85
Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol (1990) 0.84
The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening. Eur Heart J (2009) 0.84
Symptomatic distal myopathy with cardiomyopathy due to a MYH7 mutation. Neuromuscul Disord (2007) 0.84
Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy. J Mol Med (Berl) (2001) 0.83
Is the A1166C polymorphism of the angiotensin II type 1 receptor involved in cardiovascular disease? Eur Heart J (1998) 0.82
Plasma angiotensin-converting enzyme activity and left ventricular dilation after myocardial infarction. Circulation (1997) 0.82
The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects. Am J Hypertens (1996) 0.82
Early expression of natriuretic peptides and SERCA in mild heart failure: association with severity of the disease. Int J Cardiol (2001) 0.82
Hirschsprung disease and L1CAM: is the disturbed sex ratio caused by L1CAM mutations? J Med Genet (2002) 0.81
Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy. Neth Heart J (2007) 0.81
GENCOR: a national registry for patients and families suffering from a familial heart disease in the Netherlands. Neth Heart J (2006) 0.81
The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I. Heart Vessels (1997) 0.80
Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats. Br J Pharmacol (1998) 0.80
Increased risk for ischaemic events is related to combined RAS polymorphism. Heart (2001) 0.80
Encephalopathic attacks in a family co-segregating myotonic dystrophy type 1, an intermediate Charcot-Marie-Tooth neuropathy and early hearing loss. J Neurol Neurosurg Psychiatry (2009) 0.80
Exercise related ventricular arrhythmias are related to cardiac fibrosis in hypertrophic cardiomyopathy mutation carriers. Neth Heart J (2011) 0.80
Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy. Cardiovasc Res (1998) 0.79
Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators. Cardiovasc Drugs Ther (2000) 0.79
Dual pathway for angiotensin II formation in human internal mammary arteries. Br J Pharmacol (1998) 0.79
Pseudodominant inheritance of spondylocostal dysostosis type 1 caused by two familial delta-like 3 mutations. Clin Genet (2004) 0.78
Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer. Hum Reprod (2014) 0.78
Identification of a specific pattern of downregulation in expression of isoforms of vascular endothelial growth factor in dilated cardiomyopathy. Heart (2002) 0.78
Prenatal testing for Huntington's disease in the Netherlands from 1998 to 2008. Clin Genet (2013) 0.78
The TGR(mRen2)27 transgenic rat model of hypertension. Regul Pept (1998) 0.77
Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril. Cardiovasc Res (1991) 0.77
Subtelomeric chromosome aberrations: still a lot to learn. Clin Genet (2005) 0.77
Identification of a novel EYA1 mutation presenting in a newborn with laryngomalacia, glossoptosis, retrognathia, and pectus excavatum. Am J Med Genet A (2006) 0.77
Recombinant Semliki Forest virus as a vector system for fast and selective in vivo gene delivery into balloon-injured rat aorta. Gene Ther (2002) 0.77
Cardiac endothelin system impairs left ventricular function in renin-dependent hypertension via decreased sarcoplasmic reticulum Ca(2+) uptake. Circulation (2000) 0.77
Effects of angiotensin II subtype 1 receptor blockade on cardiac fibrosis and sarcoplasmic reticulum Ca2+ handling in hypertensive transgenic rats overexpressing the Ren2 gene. J Hypertens (2001) 0.76
No effect of rosuvastatin on left ventricular hypertrophy in patients with hypertension: a prospective randomised open-label study with blinded endpoint assessment. Int J Cardiol (2009) 0.76
Vectors based on Semliki Forest virus for rapid and efficient gene transfer into non-endothelial cardiovascular cells: comparison to adenovirus. Cardiovasc Res (1997) 0.75
The ACE gene polymorphism: the good, the bad and the ugly. Cardiovasc Res (1999) 0.75
[Examples of preimplantation genetic diagnosis versus prenatal diagnosis in carriers of genetic abnormalities: advantages and disadvantages]. Ned Tijdschr Geneeskd (2008) 0.75
Methods in molecular cardiology: DHPLC mutation detection analysis. Neth Heart J (2005) 0.75
The ECG of a (cardio)myopathy? Neth Heart J (2005) 0.75
Ehlers-Danlos syndrome type IV. N Engl J Med (2000) 0.75
Evaluation of exclusion prenatal and exclusion preimplantation genetic diagnosis for Huntington's disease in the Netherlands. Clin Genet (2012) 0.75
The value of (NT-pro) BNP in the diagnosis, prognosis and treatment of congestive heart failure. Neth Heart J (2004) 0.75
Activation of the renin-angiotensin system in heart failure and hypertrophy--studies in human hearts and transgenic rats. Eur Heart J (1994) 0.75
[From gene to disease; the PABN1 gene and oculopharyngeal muscular dystrophy]. Ned Tijdschr Geneeskd (2006) 0.75
Dihydropyrimidine dehydrogenase deficiency caused by a novel genomic deletion c.505_513del of DPYD. Nucleosides Nucleotides Nucleic Acids (2010) 0.75
Endothelin converting-enzyme-1 mRNA expression in human cardiovascular disease. Clin Exp Hypertens (1998) 0.75
Endothelin-converting enzyme-1 mRNA expression in human cardiovascular disease. J Cardiovasc Pharmacol (1998) 0.75
Differential inhibition of plasma versus tissue ACE by utibapril: biochemical and functional evidence for inhibition of vascular ACE activity. J Cardiovasc Pharmacol (1997) 0.75
Real-time in vivo imaging of apoptotic cell membrane changes in monocytes and macrophages. Apoptosis (2005) 0.75
Interaction of the renin-angiotensin system and the endothelin system in cardiac hypertrophy. J Cardiovasc Pharmacol (1998) 0.75
Intrachromosomal insertion translocation resulting in duplication of chromosome band Yq11.2 in two fertile brothers. Am J Med Genet A (2003) 0.75
[From gene to disease; PKHD1 and recessive polycystic kidney disease]. Ned Tijdschr Geneeskd (2005) 0.75
Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats. J Hypertens (1998) 0.75